COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE

Chemotherapy Hair Loss Treatment for Breast Cancer Patients

Treatment to minimize hair-loss during breast cancer chemotherapy treatment, with Paxman Scalp Cooling System

Women undergoing chemotherapy for breast cancer at Virginia Cancer Specialists (VCS) can now keep control of their hair loss by using a ground-breaking scalp cooling treatment.

Developed by a British family who understand first-hand what it is like to lose hair due to cancer treatment, the Paxman Scalp Cooling System helps reduce hair loss throughout chemotherapy.

Paxman Scalp Cooling empowers patients to feel a greater sense of control. That is why, here at VCS, we are delighted to be one of the first centers in the USA to be able to offer it, and the only provider in the Northern Virginia Area.

For anyone who is new to scalp cooling or has not heard of it before, find out more at www.coldcap.com.

The one-stop information site contains detailed information about what scalp cooling is, how it works, video demonstrations and even testimonials from American women who have used scalp cooling already.

So, What is Scalp Cooling?

Chemotherapy works by targeting all rapidly dividing cells in the body. Hair is the second fastest dividing cell, and this is the reason why many chemotherapy drugs cause alopecia. The hair follicles in the growth phase are attacked, resulting in hair loss approximately two weeks after the commencement of the chemotherapy treatment.

The damage that chemotherapy causes to the hair follicle can be alleviated by using the scalp cooling treatment; also known as the ‘cold cap.’ It works by reducing the temperature of the scalp by a few degrees immediately before, during and after the administration of chemotherapy.

The Next Steps

For anyone who wants to go ahead with scalp cooling, please speak with you provider and also visit www.coldcap.com which features an online resource area designed to make the whole process as easy as possible. In addition The Paxman Hub will guide you through the whole process, covering everything from patient management and nurse and physician support programs and logistics.

Once your provider completes your enrollment in to the programme the Paxman Hub will make contact with you. The Paxman Hub can also offer full support on patient information and patient assistance programs.

 

Financial Support

If you need help to pay for Paxman Scalp Cooling, don’t worry, as help is at hand. Hair To Stay is the only national non-profit subsidizing scalp cooling patients in the US. You can apply for a subsidy to help you access Paxman scalp cooling treatment at your local center by contacting the Paxman Hub. A case manager will guide you through the eligibility process. Visit www.hairtostay.org

See our Press Release Here.

“I am extremely excited to bring this new therapy to our breast cancer patients, as hair loss can be a very traumatic experience, causing unnecessary anxiety and distress. Scalp cooling gives our patients the opportunity to regain some level of normalcy, comfort and control in their lives, ensures some privacy, and helps women maintain a positive attitude about their treatment.” Amy Irwin, MD

“Scalp cooling is a safe and relatively effective method for those receiving chemo for breast cancer who are concerned about hair loss during treatment. It helps women feel like they look similar to their peers in their everyday lives. We are excited to offer this as an option to women with breast cancer and potentially contribute to their overall sense of well-being and confidence.” Neelima Denduluri, MD

Share on: